Abstract:Objective To investigate the association between serum matrix metalloproteinase-3 (MMP-3) concentrations and its 5A/6A promoter polymorphism in patients with acute coronary syndromes (ACS).Methods A total of 135 ACS patients and 71 control subjects who were free of ACS symptomes were enrolled.Serum concentrations of MMP-3 were measured by enzyme linked immunosorbent assay (ELISA).MMP-3 promoter gene was sequenced and the 5A/6A polymorphism was analyzed.Results Serum MMP-3 levels were significantly higher in AMI group than in controls(P<0.01).The distribution of MMP-3 single nucleotide polymorphism (SNP) genotype was significantly different between ACS patients and the controls (P<0.05).The 5A allele had higher frequency in ACS patients than in controls (P<0.05).The 5A allele polymorphism was strongly associated with higher serum MMP-3 levels in ACS patients.Serum MMP-3 levels were significantly higher in ACS patients with 5A/5A genotype than those with 5A/6A genotype (P<0.05).Multivariate logistic regression analysis showed that smoking,hyperlipidemia,diabetes,hypertension,as well as 5A allele polymorphism (OR 2.11,95%CI 1.23-5.11,P<0.01),were independent risk factors for ACS.Carriers of 5A allele with smoking history had a significantly increased risk (5-fold) for ACS compared with nonsmoking carriers of 6A/6A(P<0.01).Conclusion The MMP-3 5A/6A promoter polymorphism and increased MMP-3 level are significantly associated with ACS attack.The MMP-3 5A/6A promoter polymorphism exerts effects on serum MMP-3 levels.Smoking and MMP-3 5A/6A promoter polymorphism have a synergistic effect on ACS.These data suggest that MMP-3 be a useful marker for ACS,and play an important role in the induction of atherosclerosis plaque rupture.